The research dives deep into the global share, size, and trends, as well as the growth rate of the Viscosupplementation Market to project its progress during the forecast period.

 

Viscosupplementation is a treatment that relieves joint discomfort and improves the functional state of osteoarthritic joints. It entails injecting a viscous fluid known as hyaluronate into the knee. The viscous synovial fluid, which lubricates the cartilage surfaces and protects the joints from trauma, contains hyaluronic acid. This acid is an elastic material that mesothelial cells naturally release. The most prevalent type of arthritis is osteoarthritis, which is defined by loss of function and deterioration of cartilage and tissues that cover the ends of the bones in a joint.

According to Centers for Disease Control and Prevention, over 30 million people in the U.S. suffered from osteoarthritis and around 10% people over 55 years suffered from knee pain in 2015.

The study delves deeply into the global share, size, and trends of the Viscosupplementation Market, as well as the growth rate, to forecast its progress during the forecast period. Most importantly, the study highlights the past, present, and future trends that are projected to influence the Viscosupplementation market's growth rate. The market is segmented by product type, application, and geography, according to the research. To provide more clarity about the sector, the research examines the current state of several elements such as supply chain management, specialised markets, distribution channels, trade, supply, and demand, and manufacturing capability.

Viscosupplementation is a treatment that relieves joint discomfort and improves the functional state of osteoarthritic joints. It entails injecting a thick fluid known as hyaluronic acid into the knee. The synovial fluid contains hyaluronic acid (HA), which lubricates the cartilage surfaces and protects the joints from trauma. HA is a naturally occurring elastic material secreted by mesothelial cells. The most prevalent type of arthritis is osteoarthritis, which is defined by loss of function and deterioration of the cartilage and tissues that cover the ends of the bones in a joint.

The Major Manufacturers Covered In This Report: Anika Therapeutics Inc., Seikagaku Corporation, Ferring Pharmaceuticals, Bioventus, Fidia Farmaceutici S.P.A., Mylan N.V., Sanofi S.A., OrthogenRx, Teva Pharmaceutical Industries Ltd, and Johnson & Johnson.